XML 37 R26.htm IDEA: XBRL DOCUMENT

REVENUE (Tables)

6 Months Ended

Jun. 30, 2025

Revenue from Contract with Customer [Abstract]

Schedule of Total Revenue by Type and by U.S versus Rest of World

The following table presents details regarding the composition of the Company’s total revenue by product type and by geographical region, either U.S. or rest of world (“RoW”):


	Three months ended June 30,
	2025						2024
(in millions)	U.S.		RoW		Total		U.S.		RoW		Total
Hereditary Cancer	$	84.6	$	11.7	$	96.3	$	80.9	$	10.6	$	91.5
Tumor Profiling	28.3		3.1		31.4		26.7		5.9		32.6
Prenatal	47.5		0.1		47.6		44.2		0.2		44.4
Pharmacogenomics	37.8		—		37.8		43.0		—		43.0
Total revenue	$	198.2	$	14.9	$	213.1	$	194.8	$	16.7	$	211.5


	Six months ended June 30,
	2025						2024
(in millions)	U.S.		RoW		Total		U.S.		RoW		Total
Hereditary Cancer	$	160.0	$	22.6	$	182.6	$	157.2	$	22.4	$	179.6
Tumor Profiling	54.3		6.4		60.7		50.6		12.9		63.5
Prenatal	96.7		0.2		96.9		88.3		0.4		88.7
Pharmacogenomics	68.8		—		68.8		81.9		—		81.9
Total revenue	$	379.8	$	29.2	$	409.0	$	378.0	$	35.7	$	413.7